Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Praful Ravi MB BChir, MRCP

Praful K. Ravi MB BChir, MRCP

Genitourinary Medical Oncologist, Dana-Farber Cancer Institute; Instructor of Medicine, Harvard Medical School, Boston, Massachusetts

Genitourinary Medical Oncologist at Dana-Farber Cancer Institute and Instructor of Medicine at Harvard Medical School, Boston, MA.

Disclosures

No relevant disclosures reported

Recent Contributions to PracticeUpdate:

  1. Rezvilutamide vs Bicalutamide Plus ADT in Patients With High-Volume Metastatic Hormone-Sensitive Prostate Cancer
  2. Analysis of Recurrence After Neoadjuvant Bladder Cancer Treatment: Practical Implications

Most Read This Week

Recently Updated